These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 39089114)
1. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism. Qiu W; Zhang S; Yu W; Liu J; Wu H Comput Biol Med; 2024 Sep; 180():108867. PubMed ID: 39089114 [TBL] [Abstract][Full Text] [Related]
2. The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma. Chen X; Tang FR; Arfuso F; Cai WQ; Ma Z; Yang J; Sethi G Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31906046 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma. Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930 [TBL] [Abstract][Full Text] [Related]
5. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives. Hussain MS; Moglad E; Afzal M; Gupta G; Hassan Almalki W; Kazmi I; Alzarea SI; Kukreti N; Gupta S; Kumar D; Chellappan DK; Singh SK; Dua K Pathol Res Pract; 2024 Jun; 258():155303. PubMed ID: 38728793 [TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential. Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X Front Immunol; 2022; 13():985815. PubMed ID: 36300115 [TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. Hou W; Bonkovsky HL World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing. Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway. Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128 [TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Wong CM; Tsang FH; Ng IO Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776 [TBL] [Abstract][Full Text] [Related]
11. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis. Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y Front Immunol; 2024; 15():1400744. PubMed ID: 38799446 [TBL] [Abstract][Full Text] [Related]
12. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma. Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429 [TBL] [Abstract][Full Text] [Related]
13. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Fang Y; Zhang X; Huang H; Zeng Z J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling. Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055 [TBL] [Abstract][Full Text] [Related]
16. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653 [TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA in drug resistance of hepatocellular carcinoma. Ding B; Lou W; Xu L; Fan W Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380 [TBL] [Abstract][Full Text] [Related]
18. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma. Mohan CD; Rangappa S; Nayak SC; Sethi G; Rangappa KS Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188574. PubMed ID: 34062154 [TBL] [Abstract][Full Text] [Related]
20. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T; Zhu X; Zhu K; Jia F; Li S Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]